Roth Capital started coverage on shares of BUDA (NYSEAMERICAN:BUDA – Free Report) in a research report report published on Monday morning, Marketbeat reports. The firm issued a buy rating and a $12.00 target price on the stock.
BUDA Price Performance
Shares of BUDA stock opened at $8.20 on Monday. BUDA has a 12-month low of $6.25 and a 12-month high of $12.00. The firm has a fifty day moving average of $8.17 and a 200-day moving average of $8.93.
BUDA (NYSEAMERICAN:BUDA – Get Free Report) last announced its earnings results on Friday, August 14th. The company reported $0.04 earnings per share for the quarter. The company had revenue of $4.51 million during the quarter. Research analysts anticipate that BUDA will post 0.11 EPS for the current fiscal year.
About BUDA
Buda Juice, Inc (NYSE American: BUDA) is a beverage company focused on producing and selling organic, cold-pressed juice products. Its offerings are designed to provide convenient, ready-to-consume beverages made from fruit, vegetables and other plant-based ingredients.
The company’s product portfolio includes cold-pressed juice shots and related functional beverage products, with formulations intended to support wellness and everyday nutrition. Buda Juice products are marketed through retail, natural and specialty food channels, as well as other distribution outlets.
Buda Juice serves consumers seeking refrigerated, minimally processed and plant-based beverage options.
See Also
- Five stocks we like better than BUDA
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for BUDA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BUDA and related companies with MarketBeat.com's FREE daily email newsletter.
